In metabolic disorders such as diabetic nephropathy, changes in SQOR expression and activity are also closely tied to disease progression (Kanemaru et al., 2024; Lee et al., 2025; Bushell et al., 2023). This evidence concerns the gene SQOR and diabetic kidney disease.